...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
Medicine Products:(Date:12/2/2008)...tatives from the fitness,company Burn Machine ( w...rs,Hospitals for Children in Chicago last month t...cause; The Burn Machine donated more than $1500,w...the first ever Shriners,Wheelchair Bodybuilding C...-bin/prnh/20081203/CLW007 ) , "We knew the...
(Date:12/2/2008)...stantially higher rates of mental health problems ...from a systematic review and meta-analysis publish... studies over the past four decades containing dat...s people, Seena Fazel and colleagues of the Univer...84 homeless individuals based in the US, UK, mainl...
(Date:12/2/2008)...oups of immigrants in Oslo. Compared with Norwegia...s are seen for risk factors and actual diseases. T...stitute of Public Health. Five of the largest immi... ethnic Norwegian population. The report was commi... The five immigrant groups in this study come fro...
(Date:12/2/2008)...k, data review finds , , TUESDAY, Dec. 2... on the safety of the drug Trasylol (aprotinin), u...ry. , Trasylol is already the subject of contro...rom the market in 2007. , In the new study, Can... from 49 randomized clinical trials. They conclude...
Breaking Medicine News(10 mins):Health News:Burn Machine Speed Bag Knocks 'em Out at Shriners Wheelchair Bodybuilding Camp 2Health News:Large health differences between population groups in Norway 2Health News:Large health differences between population groups in Norway 3Health News:Large health differences between population groups in Norway 4Health News:Another Study Warns of Risk From Cardiac Surgery Drug 2(Date:12/1/2008)..., Pa., Dec. 1 Genaera C...dosing of subjects has begun in study MSI-1436C-10...b study of trodusquemine (MSI-1436) in overweight ...erapeutic for the treatment of type 2 diabetes and... regulate insulin and leptin pathways through the ...
(Date:12/1/2008)... GeoVax Labs, Inc.,(OTC ...ogy company developing,human vaccines for disease...nd,other infectious agents, announced today that ...ill take place in twelve sites across North and So...oration with The National Institutes of,Health (N...
(Date:11/30/2008)... Abnormalities in audito...ldren with autism spectrum disorder by using magne...ented today at the annual meeting of the Radiologi...sing MEG, we can record the tiny magnetic fields a...mothy Roberts, Ph.D., vice chair of research in th...
(Date:11/27/2008)...the majority of acute lymphoblastic leukemia relap...time of diagnosis , , MEMPHIS, Tenn., Nov. ...de Children,s Research Hospital have identified di...hildren with acute lymphoblastic leukemia (ALL) th...designing treatments for ALL relapse in children a...
Breaking Medicine Technology:Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3Brain Waves Show Sound Processing Abnormalities in Autistic Children 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 3St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System 28TM 29 and RenalGuard Therapy 28TM 29 1100 1PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System 28TM 29 and RenalGuard Therapy 28TM 29 1100 2PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System 28TM 29 and RenalGuard Therapy 28TM 29 1100 3PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System 28TM 29 and RenalGuard Therapy 28TM 29 1100 4WellPoint Announces Appointment of John Langenus as President of Anthem National Accounts 8538 1WellPoint Announces Appointment of John Langenus as President of Anthem National Accounts 8538 2WellPoint Announces Appointment of John Langenus as President of Anthem National Accounts 8538 3WellPoint Announces Appointment of John Langenus as President of Anthem National Accounts 8538 4BAXL Technologies Partners With Epikinonia at Maternity Clinic in Athens Greece 8535 1BAXL Technologies Partners With Epikinonia at Maternity Clinic in Athens Greece 8535 2Washington Capitals Player White House Columnist Take Fundraising Online for Childrens National Medical Center 8532 1Washington Capitals Player White House Columnist Take Fundraising Online for Childrens National Medical Center 8532 2...NEVA, Switzerland, May 2, 2007 – Merck,Seron...I data on,safinamide, a new agent in Phase III dev...sease symptoms, were presented by Professor,Fabriz...th Annual,Meeting in Boston, Massachusetts, USA. T...d, double blind, placebo-controlled,international...
...ublished today in the Journal of the National Canc...and, 2 May 2007 - In a study published today in,th...novative cancer,drug MabThera was shown to improve...less of the chemotherapy regimen used.1 The,review...as seen for,the first time in patients with mantle...
Other Medicine Technology:Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 2Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 3Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 4Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 5MabThera Significantly Increases Survival of Lymphoma Patients,Regardless of Chemotherapy Regimen 2MabThera Significantly Increases Survival of Lymphoma Patients,Regardless of Chemotherapy Regimen 3MabThera Significantly Increases Survival of Lymphoma Patients,Regardless of Chemotherapy Regimen 4